a couple of big announcements out so far this morning!
AHZ has demonstrated outstanding performance of CardioCel® in the reconstruction of heart valves compared to the control, and notably that valves in the CardioCel® repaired group demonstrated significantly reduced calcification versus the control as well as minimal thickening of the tissue.
In what will be even bigger news, SPL has gone into a trading halt before the release of its Phase III trial results before the start of trade tomorrow. Definitely one to watch!
- Forums
- ASX - By Stock
- biotech thread - wednesday 28th november
biotech thread - wednesday 28th november, page-2
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online